Lazard Asset Management’s AngioDynamics ANGO Stock Holding History

Lazard Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.76M	Buy	154,578 +143,755	+1,328%	+$1.56M	﹤0.01%	956
2025 Q4	$139K	Buy	+10,823	New	+$134K	﹤0.01%	1706
2023 Q4	–	Sell	-5,727	Closed	-$41K	–	2244
2023 Q3	$41K	Buy	+5,727	New	+$47.7K	﹤0.01%	1907
2023 Q2	–	Sell	-5,351	Closed	-$55K	–	2287
2023 Q1	$55K	Buy	5,351 +416	+8%	+$5.33K	﹤0.01%	1760
2022 Q4	$67K	Hold	4,935	–	–	﹤0.01%	1677
2022 Q3	$100K	Sell	4,935 -1,647	-25%	-$36.2K	﹤0.01%	1477
2022 Q2	$127K	Buy	6,582 +1,518	+30%	+$31.1K	﹤0.01%	1421
2022 Q1	$109K	Sell	5,064 -3,933	-44%	-$89.2K	﹤0.01%	1373
2021 Q4	$247K	Buy	+8,997	New	+$248K	﹤0.01%	1234
2019 Q4	–	Sell	-1,556,054	Closed	-$28.7M	–	1523
2019 Q3	$28.7M	Buy	1,556,054 +44,252	+3%	+$865K	0.05%	271
2019 Q2	$29.8M	Sell	1,511,802 -88,046	-6%	-$1.79M	0.05%	270
2019 Q1	$36.6M	Buy	1,599,848 +1,114	+0.1%	+$24.2K	0.06%	214
2018 Q4	$32.2M	Buy	1,598,734 +79,683	+5%	+$1.65M	0.06%	212
2018 Q3	$33M	Buy	1,519,051 +912,318	+150%	+$20.3M	0.05%	230
2018 Q2	$13.5M	Buy	+606,733	New	+$12.4M	0.02%	367

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Lazard Asset Management's ANGO Position: Q1 2026 in Review

Lazard Asset Management increased its AngioDynamics (ANGO) stake by 1,328% in Q1 2026, buying an estimated $1.56M and bringing the position to 154,578 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #956.

Lazard Asset Management first reported a position in ANGO in Q2 2018 and has held it in 15 quarters since. The position peaked at $36.6M in Q1 2019. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Lazard Asset Management held 154,578 shares of AngioDynamics worth $1.76M as of Q1 2026.
Lazard Asset Management bought 143,755 AngioDynamics shares in Q1 2026, an estimated $1.56M.
AngioDynamics made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #956 holding.
Lazard Asset Management first reported a position in AngioDynamics in Q2 2018 and has held it in 15 quarters since.
Lazard Asset Management's AngioDynamics position peaked at $36.6M in Q1 2019.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.